106 related articles for article (PubMed ID: 16722229)
1. Molecular microfluorometry: converting arbitrary fluorescence units into absolute molecular concentrations to study binding kinetics and stoichiometry in transporters.
Schwartz JW; Piston D; DeFelice LJ
Handb Exp Pharmacol; 2006; (175):23-57. PubMed ID: 16722229
[TBL] [Abstract][Full Text] [Related]
2. Substrate binding stoichiometry and kinetics of the norepinephrine transporter.
Schwartz JW; Novarino G; Piston DW; DeFelice LJ
J Biol Chem; 2005 May; 280(19):19177-84. PubMed ID: 15757904
[TBL] [Abstract][Full Text] [Related]
3. Binding and transport in norepinephrine transporters. Real-time, spatially resolved analysis in single cells using a fluorescent substrate.
Schwartz JW; Blakely RD; DeFelice LJ
J Biol Chem; 2003 Mar; 278(11):9768-77. PubMed ID: 12499385
[TBL] [Abstract][Full Text] [Related]
4. Cell-type-specific expression of catecholamine transporters in the rat brain.
Lorang D; Amara SG; Simerly RB
J Neurosci; 1994 Aug; 14(8):4903-14. PubMed ID: 8046459
[TBL] [Abstract][Full Text] [Related]
5. Handling of intracellular K
Bhat S; Niello M; Schicker K; Pifl C; Sitte HH; Freissmuth M; Sandtner W
Elife; 2021 Jun; 10():. PubMed ID: 34061030
[TBL] [Abstract][Full Text] [Related]
6. Influence of ligand binding kinetics on functional inhibition of human recombinant serotonin and norepinephrine transporters.
Tsuruda PR; Yung J; Martin WJ; Chang R; Mai N; Smith JA
J Pharmacol Toxicol Methods; 2010; 61(2):192-204. PubMed ID: 20036748
[TBL] [Abstract][Full Text] [Related]
7. Validation of a fluorescence-based high-throughput assay for the measurement of neurotransmitter transporter uptake activity.
Jørgensen S; Nielsen EØ; Peters D; Dyhring T
J Neurosci Methods; 2008 Mar; 169(1):168-76. PubMed ID: 18222006
[TBL] [Abstract][Full Text] [Related]
8. Dynamic monitoring of NET activity in mature murine sympathetic terminals using a fluorescent substrate.
Parker LK; Shanks JA; Kennard JA; Brain KL
Br J Pharmacol; 2010 Feb; 159(4):797-807. PubMed ID: 20136837
[TBL] [Abstract][Full Text] [Related]
9. A second extracellular site is required for norepinephrine transport by the human norepinephrine transporter.
Wang CI; Shaikh NH; Ramu S; Lewis RJ
Mol Pharmacol; 2012 Nov; 82(5):898-909. PubMed ID: 22874414
[TBL] [Abstract][Full Text] [Related]
10. Novel fluorescence-based approaches for the study of biogenic amine transporter localization, activity, and regulation.
Mason JN; Farmer H; Tomlinson ID; Schwartz JW; Savchenko V; DeFelice LJ; Rosenthal SJ; Blakely RD
J Neurosci Methods; 2005 Apr; 143(1):3-25. PubMed ID: 15763132
[TBL] [Abstract][Full Text] [Related]
11. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
Wall SC; Gu H; Rudnick G
Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
[TBL] [Abstract][Full Text] [Related]
12. Norepinephrine transport-mediated gene expression in noradrenergic neurogenesis.
Hu YF; Caron MG; Sieber-Blum M
BMC Genomics; 2009 Apr; 10():151. PubMed ID: 19356247
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning and characterization of an L-epinephrine transporter from sympathetic ganglia of the bullfrog, Rana catesbiana.
Apparsundaram S; Moore KR; Malone MD; Hartzell HC; Blakely RD
J Neurosci; 1997 Apr; 17(8):2691-702. PubMed ID: 9092590
[TBL] [Abstract][Full Text] [Related]
14. High-throughput screening for norepinephrine transporter inhibitors using the FLIPRTetra.
Wagstaff R; Hedrick M; Fan J; Crowe PD; DiSepio D
J Biomol Screen; 2007 Apr; 12(3):436-41. PubMed ID: 17438071
[TBL] [Abstract][Full Text] [Related]
15. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity.
Miller GM; Yatin SM; De La Garza R; Goulet M; Madras BK
Brain Res Mol Brain Res; 2001 Feb; 87(1):124-43. PubMed ID: 11223167
[TBL] [Abstract][Full Text] [Related]
16. Patch-clamp and amperometric recordings from norepinephrine transporters: channel activity and voltage-dependent uptake.
Galli A; Blakely RD; DeFelice LJ
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13260-5. PubMed ID: 9789076
[TBL] [Abstract][Full Text] [Related]
17. Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters.
Zhang S; Fernandez F; Hazeldine S; Deschamps J; Zhen J; Reith ME; Dutta AK
J Med Chem; 2006 Jul; 49(14):4239-47. PubMed ID: 16821783
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.
Han DD; Gu HH
BMC Pharmacol; 2006 Mar; 6():6. PubMed ID: 16515684
[TBL] [Abstract][Full Text] [Related]
19. Norepinephrine transporters have channel modes of conduction.
Galli A; Blakely RD; DeFelice LJ
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8671-6. PubMed ID: 8710929
[TBL] [Abstract][Full Text] [Related]
20. Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells.
Siebert GA; Pond SM; Bryan-Lluka LJ
Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):255-64. PubMed ID: 10731037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
